The Center for Immunology is an interdisciplinary research program at the University of Minnesota devoted to advancing the field of immunology and educating future immunologists.

Autoimmunity Cancer Vaccines Cures

Latest News 


RED Seminar Series Returns!!
Red Series


The RED Seminars are back and in-person. They will be happening every first Monday of the month 9:00 - 10:30 AM in 1-125 CCRB. The focus of these is on peer-to-peer science communication. You may have seen the latest issue of Science editorial discussing the importance of this. It referred to the Alan Alda Center for Communicating Science. The CFI history of investing into training in science communication actually precedes that! This year we will be returning to our original coach, Chris Carlson.



CFI welcomes our newest faculty member, Michael Lipscomb, PhD

M. LipscombThe Center for Immunology is thrilled to welcome Michael Lipscomb, PhD to the University of Minnesota and to our group housed in WMBB where he will have a satellite lab as part of his larger lab housed in NHH. Dr. Lipscomb is an Associate Professor in the Department of Pharmacology. He received his BS from the University of California Los Angeles with a degree in Microbiology, Immunology, and Molecular Genetics prior to receiving a Ph.D. in Immunology from the University of Pittsburgh. His postdoctoral training was at the University of Pennsylvania and Children’s Hospital of Philadelphia. Prior to coming to the University of Minnesota, Dr. Lipscomb held a faculty position at Howard University where he built a productive, visible, and independent research program studying immunobiology, with concentrations in immunoregulation, autoimmunity, immunology of infectious disease, and employment of biomaterials and microcarrier systems for organoid tissue development. The focus of his laboratory at the University of Minnesota is to mechanistically describe the immunoregulatory network(s) that govern the differentiation and function of antigen-presenting myeloid cells both under steady-state and disease settings. In addition, his laboratory employs the use of novel biomaterials to generate organoids for tissue restorative therapies, with the chief aim to resolve chronic autoimmune disorders and immunodeficiencies. Dr. Lipscomb is currently funded by the Maximizing Investigator Research Award (MIRA; R35 mechanism) and an R21 exploratory research grant. Dr. Lipscomb is also serving as the interim Associate Dean for Graduate Education. One of the goals of the Medical School during this transition period will be to step back and examine the existing graduate education program in the context of the current issues facing graduate and postdoctoral programs nationwide to see where we can strengthen and enhance those things that are working well. Stop by his office in Nils Hasselmo Hall 3-108 to visit and introduce yourself. For more info, click here.


Kris Hogquist is elected to the National Academy of Sciences

Hogquist NAS 2022CFI is honored to announce that our Associate Director Kristin Hogquist, Ph.D. has been elected to the National Academy of Sciences. The National Academy of Sciences elects new members in recognition of their distinguished and continuing achievements in original research. Membership is a widely accepted mark of excellence in science and is considered one of the highest honors that a scientist can receive. Current NAS membership totals approximately 2,400 members and 500 foreign associates, of which approximately 190 have received Nobel prizes. Established in 1863 by Abraham Lincoln, the NAS is charged with providing independent, objective advice to the nation on matters related to science and technology. Scientists are elected by their peers to membership in recognition of their distinguished and ongoing achievements in original research. Membership is widely considered one of the highest honors that a scientist can receive.  "It's great to see Kris recognized for her pioneering research. Her consistent line of investigation on a fundamental problem is a shining example to us all." noted CFI Director Dr. Marc Jenkins. A celebration of Kris's accomplishments was held on June 28, 2022.  Read more here
Kris reception 6-28-22



Congratulations to Dr. Harry Orr, 2022 recipient of the Kavli Prize in Neuroscience

2022 Harry Orr

The Kavli Foundation and the Norwegian Ministry of Education and Research announced June 1, 2022 that LMP professor Harry Orr is one of four winners of the 2022 Kavli Prize in Neuroscience.  Named after Fred Kavli, a Norwegian-American physicist, entrepreneur and philanthropist, the biennial Kavli Prize “honors scientists for breakthroughs in astrophysicsnanoscience and neuroscience – transforming our understanding of the big, the small and the complex.”  Orr was honored for his pioneering genetic research on the neurodegenerative disease spinocerebellar ataxia type 1 (SCA1), a collaborative effort with Baylor College of Medicine’s Huda Zogbhi, also a 2022 Kavli Prize winner.  He will travel to Norway to receive the prize from Haakon, Crown Prince of Norway, in September.  Each Kavli Prize consists of a gold medal, a scroll, and a cash award of $1 million, which is shared among the winners in each category.  Congratulations Harry!  Read more here.



2020 congratulations

Spring has been a busy time for CFI members: 

Dr. Jesse Williams was awarded an NIH R01 grant "Sex and stress hormones control adrenal gland macrophage development and function" and a MN Department of Health grant to study monocyte trafficking following traumatic brain injury.

Dr. Matouš Vobořil, a postdoctoral fellow in the Hogquist lab, has been awarded a CRI Irvington Postdoctoral Fellowship.

Natalie David, MSTP/MICaB graduate student in the Farrar Lab was awarded the 2022 President’s Student Leadership & Service Award (PSLSA), this award recognizes the accomplishments and contributions of outstanding student leaders for their service to the University of Minnesota Twin Cities and the surrounding community.

Monica Sauer, BMBB graduate student in the Freedman Lab has been awarded the 2022 Armstrong-Pothapragada Graduate Fellowship by the Department and Graduate Program in Biochemistry, Molecular Biology & Biophysics. "This fellowship is given to a talented student who is in good standing and shows potential in their chosen field."

Dr. Ingunn Stromnes, received an R01 from National Cancer Institute entitled, "Enhancing engineered T cell therapeutic efficacy for the treatment of pancreatic ductal adenocarcinoma". (Co-Investigators are Drs. Stephen Shen, Xavier Revelo, Beau Webber). She also received one of the first Idea Awards from the Department of Defense for pancreatic cancer research entitled : “Manipulating Myeloid Cells to Promote Immunotherapy Efficacy of Pancreatic Ductal Adenocarcinoma" (Co-Investigators are Drs. Jesse Williams and Kaylee Schwertfeger)

Dr. Nicholas Maurice, a postdoc in Stephen Jameson’s lab, was awarded a one-year grant from the National Cancer Institute (NCI) to study his proposal “Profiling and leveraging bystander T cells within the tumor microenvironment.”

Congratulations to everyone!!


CFI debuts new “CFI Legends Wall”

CFI Legends WallRecently a new wall of recognition was added to the Center for Immunology. To commemorate over 25 years of outstanding research, CFI is honoring two of the founding members of the Center for Immunology, Drs. Tucker LeBien and Matthew Mescher. Dr. LeBien was instrumental in revitalizing immunology as a discipline at the University of Minnesota. After the hiring of a prominent immunologist, Dr. Matthew Mescher in 1993, both LeBien and Mescher worked together to organize all of the UMN immunologists from several departments throughout the medical school. Once organized the group of 11 other faculty members formed a new graduate program to enhance the visibility of training opportunities in immunology. Mescher then applied for grants to establish contiguous research space and in 1995 the official Center for Immunology was launched. Mescher was named the first CFI director and continued to lead the center until 2013 when he stepped down. LeBien continued to support the CFI at an administrative level as the Vice Dean for Research in the Medical School and Associate Vice President for Research in the Academic Health Center until his retirement in January 2022.  CFI is thrilled to begin the wall with two strong leaders. Stop by the 2nd floor WMBB to see the beautiful tributes to each of the legends.
Mescher       Drs. Tucker LeBien, Harry Orr, and         CFI director Marc Jenkins










Join AIRE and EWIS for our monthly discussions on race and gender inequality!!

  • Enhanced CD4+ and CD8+ T cell infiltrate within convex hull defined pancreatic islet borders as autoimmune diabetes progresses

    Nature's Scientific Reports, August 25, 2021 issue has an article by Alex Dwyer in the Fife lab on a new process to identify islet damage where he introduces an automated convex hull-based analytical procedure using a macro written in FIJI for inflammation. This new tool could elevate inflammation for diabetes assessment and inflammation in general. Read more here:

  • CD40 Agonist Overcomes T Cell Exhaustion Induced by Chronic Myeloid Cell IL-27 Production in a Pancreatic Cancer Preclinical Model

    The Stromnes lab was recently awarded an RO1 based on the work led by Dr. Adam Burrack. His recent first author  J. Immunol and Cell Report papers have identified a mechanistic basis for T cell exhaustion in pancreatic cancer and a feasible clinical strategy to overcome it.

  • Expansible residence decentralizes immune homeostasis

    While working on his doctoral thesis in the Masopust lab, Sathi Wijeyesinghe found that expansibility and tissue residency are generalizable qualities that underlie immune homeostasis, building on our initial exploration of resident memory T cell durability and maintenance, his "story" can be read in the March 2021 edition of Nature.

  • MHC class II tetramers engineered for enhanced binding to CD4 improve detection of antigen-specific T cells.

    In the May 2021 issue of Nature Biotechnology, a study led by Dr. T. Dileepan from the Jenkins group examined the effect of MHC class II tetramers engineered for enhanced binding, to improve the detection of low-affinity CD4 antigen-specific T cells

  • T cell memory: Understanding COVID-19

    As the SARS-CoV-2 pandemic has progressed, increasing attention has focused on establishing natural and vaccine-induced immunity against this coronavirus and the disease, COVID-19, that it causes. In the 2021 preprint issue of Immunity, Jarjour, Masopust and Jameson explain the fundamental features of T cell memory and their potential relevance for effective immunity to SARS-CoV-2. Read here
  • Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression

    A study published in Nature Immunology which was led by Jesse Williams has formed new answers regarding atherosclerosis, the build-up of fats, cholesterol and other substances in and on the artery walls. Read here.

Research ethics at the University of Minnesota

We are committed to protecting research participants, upholding ethical standards, and improving our practice at every step of our work.

Learn more about our commitment to research ethics 


Tea and Talk!!
Mondays and Thursdays
2:00-2:30pm| 2-163 WMBB
COVID-19 Scientific Daily Update
Mon. Seminars: Nov. 28

Immunology Journal Club

9:00-10:00am|3-143 WMBB|Zoom 
MICaB-Immunology Invited Speaker Seminar

"The intersection of cellular transcription and retrovirus assembly"

Leslie Parent, MD
Department of Microbiology and Immunology, Penn State
Host: Kathleen Boris-Lawrie, PhD (

12:00-1:00pm|1-125 CCRB| Zoom 
CFI Tea and Talk Time

2:00-2:30 pm|2-163 WMBB
BGREAT and OPD Seminars:
Check calendar for all info/events
Tues. Seminars: Nov. 29

Cancer Center Seminar Series
Check website for Zoom info.

"Increasing Colorectal Cancer Equity: Mistrust & Men & Masculinity, Oh My!"

Charles R. Rogers, Ph.D, MPH, MS, MCHES®
Associate Professor, Institute for Health & Equity
MCW Cancer Center

9-10 am|1-125 CCRB| Zoom
Center for Inflammation Science Seminar Series  

“How macrophages return organs to homeostasis  in infections, acute injury and chronic disease”  

Paul Kubes, PhD 
Professor, Department of Physiology & Pharmacology and Medicine 
Lead: VPR Strategic Research Priority – Infections Inflammation and Chronic Diseases 
University of Calgary 


9:30am – 10:30am|2-102 CMRR
BGREAT and OPD Seminars:
Check calendar for all events

Constructive Communication
2pm – 3pm|Register
Wed. Seminars: Nov. 30

All-Medical School COVID-19 Forum
Next Meeting: Dec. 7 or check here
BGREAT and OPD Seminars:
Check calendar for all events
Lillehei Heart Institute Lecture Series

"Resident Cardiac Macrophages and Myocardial Remodeling"

Kory Lavine, M.D., Ph.D.
Associate Professor of Medicine
Cardiovascular Division
Washington University

12:00-1:00pm|1-101 MRF|Webcast
Immunology Supergroup
Returns Nov. 30

1:30-2:30 pm|1-125 CCRB|Zoom
Thurs. Seminars: Dec. 1

MICaB Student Seminar Series

Functional genomics of polymicrobialinteractions and uncharacterized genes in Gram-positive bacteria

Julia Willett, Ph.D., Department of Microbiology and Immunology, MICaB Graduate Faculty Candidate
Faculty Advocate: Ryan Hunter

12:00-1:00|1-110 LRB/MTR|Zoom
IBP/MD Center Seminar Series
Dr. Beshay Zordoky

12:00-1:00 p.m.|1-125 CCRB|Zoom
CFI Tea and Talk Time

2:00-2:30pm|2-163 WMBB
BGREAT and OPD Seminars 
Check calendar for all events
Fri. Seminars: Dec. 2

BGREAT and OPD Seminars 
Check calendar for events

Leaving academia? Here's what you need to do to prepare
11am – 12pm|Register


Save the date:

December 5


Amy Moran, PhD
Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR
Host: Kris Hogquist (

12:00-1:00pm|1-125 CCRB| Zoom 

Grant opportunities